What Is MRSA Nares and How Is It Treated?

MRSA nares refers to colonization of the anterior nose (the nares) by methicillin-resistant Staphylococcus aureus, a strain of staph bacteria that resists several common antibiotics. Carrying MRSA in your nose does not mean you have an active infection, but it does raise your risk of developing one, and it can spread the organism to others. Treatment centers on a topical antibiotic ointment called mupirocin, often combined with antiseptic body washes, though the picture gets more complicated when resistance, recurrence, and extra-nasal body sites enter the equation.

Why MRSA Likes the Nose

The inside of your nostrils is not random real estate for bacteria. The anterior nares are lined with skin-like epithelial cells that shed in tiny flakes called squames, and MRSA has evolved molecular tools that latch onto the structural proteins in those flakes. Specific bacterial surface proteins bind to components of the skin’s outer layer, including loricrin and keratin 10. Another bacterial surface molecule interacts with a receptor on deeper nasal epithelial cells, giving MRSA a second foothold further inside the nasal cavity.1Trends in Microbiology. What Is MRSA Nares and How Is It Treated? – Section: Figure 2 This two-pronged adhesion strategy helps explain why the nose is the single most common reservoir for staph on the human body, and why a simple swab of the nostrils is the standard way to check whether someone is carrying it.

Carrying MRSA Versus Having an Infection

The distinction between colonization and infection trips up a lot of people. Colonization means the bacteria are present and multiplying on your body surfaces without causing symptoms. You feel fine. There is no redness, no pus, no fever. But that does not mean the bacteria are harmless passengers. A meta-analysis found that nasal colonization with MRSA was associated with roughly a four-fold increase in the odds of developing an actual MRSA infection compared to people who were not colonized.2PubMed. The risk of infection after nasal colonization with Staphylococcus aureus In a four-year follow-up study of hospitalized patients, about 18% of those carrying MRSA in their noses went on to develop a MRSA infection, compared with only about 4% of noncarriers.3PubMed Central. MRSA nasal colonization burden and risk of MRSA infection

An interesting nuance from that same study: having a heavier load of MRSA in the nose did not appear to increase infection risk any further beyond what a lighter load already conferred. In other words, even a low-density carrier faces substantially elevated risk. This matters because low-density carriers are the hardest to detect on routine screening, as we’ll see shortly.

Who Is Most Likely to Carry MRSA in the Nose

MRSA nasal carriage rates vary enormously depending on where and whom you test. In the general community, carriage tends to be low. A study of adults in Queensland, Australia, found that only about 0.7% carried MRSA nasally.4PubMed. Nasal carriage of Staphylococcus aureus, including community-associated methicillin-resistant strains, in Queensland adults Among university students in Ethiopia, overall staph nasal colonization was around 13%, but the MRSA subset was about 6%.5PubMed Central. Nasal carriage rate, associated factors, and antimicrobial susceptibility patterns of methicillin resistance Staphylococcus aureus among pre-clinical undergraduate students at the College of Health and Medical Sciences, Haramaya University, Ethiopia Rates climb sharply in hospitals and among medically vulnerable populations.

Several factors consistently push the odds of nasal carriage higher:

How Screening Works

MRSA nasal screening is straightforward from the patient’s perspective: a nurse or technician rotates a swab inside both nostrils for a few seconds. What happens to that swab in the lab, though, matters for accuracy and speed. Two main approaches are used: culture-based methods and PCR (a rapid molecular test).

Culture involves placing the swab on a special plate that selectively grows MRSA. It is cheap and reliable for moderate to heavy colonization, but it takes 24 to 48 hours and can miss carriers who harbor only a small amount of MRSA. One study found that discrepancies between culture and PCR mostly arose at low bacterial densities, and low-density carriage turned out to be the most common carrier state. Enriching the sample in broth before plating it improved detection, bringing culture performance close to PCR results.8PubMed Central. Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares

PCR-based tests amplify a gene specific to MRSA and can deliver results in about an hour. In a comparison against chromogenic agar culture in ICU patients, a PCR assay achieved 100% sensitivity and caught every positive case, though its positive predictive value was lower because some samples flagged as positive grew only methicillin-susceptible staph on culture.9PubMed Central. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from intensive care unit patients The speed advantage of PCR is its biggest selling point: hospitals can place patients into appropriate precautions on the day of admission rather than waiting two days for a culture result.

The Value of Preoperative Nasal Screening

Many surgical programs now swab patients’ noses before operations so they can adjust the antibiotics given at the time of surgery. The value of this practice depends on the clinical context. In pediatric spine surgery, preoperative MRSA screening changed the antibiotic plan in up to about 6.5% of patients, making it a low-cost tool worth incorporating into surgical planning.10PubMed. Preoperative MRSA Screening in Pediatric Spine Surgery: A Helpful Tool or a Waste of Time and Money? But a study looking at children undergoing a specific hip procedure found that preoperative MRSA nasal swab results had no relationship to surgical site infection rates and no impact on clinical care.11PubMed Central. Pre-operative methicillin resistant Staphylococcus aureus results do not predict surgical site infections in children undergoing varus derotational osteotomy The takeaway is that universal preoperative screening pays off most when the surgery involves implanted hardware or high infection stakes, where changing the antibiotic choice can plausibly prevent a devastating complication.

Mupirocin and the Standard Decolonization Approach

Mupirocin nasal ointment is the front-line treatment for clearing MRSA from the nose. You apply a small amount inside each nostril, typically twice a day for five days. The drug works by blocking a step in bacterial protein synthesis, and it is potent against gram-positive organisms like staph. Immediately after completing a course, somewhere between 80% and 100% of patients test negative for nasal staph, compared with spontaneous clearance rates well below 50%.12Journal of Antimicrobial Chemotherapy. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects

A Cochrane review pooling eight trials found that mupirocin reduced subsequent staph infections by about 45% compared with placebo or no treatment.13Cochrane Database of Systematic Reviews. Mupirocin nasal ointment for preventing Staphylococcus aureus infections in nasal carriers That is a meaningful reduction, especially for people heading into surgery or those with chronic conditions that make staph infections dangerous. Mupirocin is also effective at reducing overall carriage when the nose is the primary site, though it is notably less effective at clearing staph from the throat or groin.14PubMed Central. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults

Combining Mupirocin With Chlorhexidine

Because MRSA often colonizes body sites beyond the nose, many hospital protocols pair mupirocin ointment with chlorhexidine, an antiseptic used as a body wash or rinse, and sometimes as a mouthwash. A major trial (the CLEAR Trial) tested this combination in recently discharged MRSA carriers. Participants who used chlorhexidine baths, chlorhexidine mouthwash, and nasal mupirocin for five days twice a month over six months had a 30% lower risk of MRSA infection than those who received education alone.15PubMed Central. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers A secondary analysis of the same trial showed that the decolonization group had markedly lower MRSA colonization at multiple body sites by one month, and the effect persisted through nine months.16PubMed Central. Chlorhexidine and Mupirocin for Clearance of Methicillin-Resistant Staphylococcus aureus Colonization After Hospital Discharge

In ICU settings, a large cluster-randomized trial compared three strategies: screening and isolation only, targeted decolonization of known carriers, and universal decolonization of all ICU patients regardless of MRSA status. Universal decolonization outperformed both other approaches, cutting bloodstream infections from any pathogen by about 44% relative to baseline and reducing MRSA clinical isolates by about 37%.17PubMed Central. Targeted versus universal decolonization to prevent ICU infection A cost-effectiveness analysis found that targeted decolonization was the least costly strategy overall, while universal decolonization prevented the most infections but at a considerably higher cost per infection averted.18JAMA Network Open. Universal vs Targeted Chlorhexidine Bathing and Nasal Decolonization in Hospitalized Patients

When Mupirocin Stops Working

Mupirocin resistance is a growing headache. The more a facility uses mupirocin, the more likely resistant strains emerge. High-level resistance, driven by a specific gene called mupA, is linked to multidrug resistance, meaning the strains that shrug off mupirocin tend to resist chlorhexidine too. Among MRSA isolates, genes encoding chlorhexidine resistance have been found in 65% to 91% of samples in some studies.19Journal of Antimicrobial Chemotherapy. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA That pairing undermines the standard decolonization bundle of mupirocin plus chlorhexidine.

Even so, mupirocin is not completely useless against resistant strains. A study found that mupirocin still cleared about 52% of patients colonized with mupirocin-resistant MRSA, compared with 68% of those carrying susceptible strains. Among patients colonized only in the nose, clearance was lower for resistant strains (about 44% versus about 86%), but still happened in a meaningful proportion of cases.20PubMed. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains

Povidone-Iodine as a Short-Term Alternative

For situations where mupirocin resistance is a concern, or when you need quick, short-lived suppression right before surgery, povidone-iodine preparations offer an option. A randomized trial found that a single application of 10% povidone-iodine significantly reduced nasal MRSA at one and six hours after application, but the effect did not last beyond 12 hours.21PubMed. Efficacy of a povidone iodine preparation in reducing nasal methicillin-resistant Staphylococcus aureus in colonized patients Another study compared an off-the-shelf povidone-iodine solution with a surgical-grade nasal antiseptic formulation and saline. The surgical-grade product significantly reduced staph colonization at four hours, but by 24 hours there was no significant difference between any of the groups.22PubMed. Povidone-Iodine-Based Solutions for Decolonization of Nasal Staphylococcus aureus: A Randomized, Prospective, Placebo-Controlled Study

Laboratory work using nasal tissue models showed that a surgical nasal povidone-iodine prep reduced MRSA counts by more than 99% regardless of whether the strain was mupirocin-resistant, and it even prevented MRSA from establishing itself when applied before bacterial exposure.23PubMed Central. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares The practical upshot: povidone-iodine works well as a same-day perioperative measure, but it is not a substitute for mupirocin when you need sustained decolonization over days or weeks.

Systemic Antibiotics for Stubborn Cases

When MRSA colonizes sites beyond the nose, topical mupirocin and antiseptic washes may not be enough. A narrative review concluded that the standard mupirocin-plus-antiseptic approach appears insufficient for patients with extra-nasal colonization, and the best-supported add-on is a combination of rifampin with another oral antibiotic, layered on top of topical therapy.24Clinical Microbiology and Infection. Strategies for elimination of methicillin-resistant Staphylococcus aureus colonization: a narrative review An older study demonstrated success with a regimen of oral minocycline and rifampin combined with nasal mupirocin for patients colonized at multiple body sites.25PubMed Central. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin Systemic antibiotics carry their own risks (side effects, promoting further resistance), so they are generally reserved for patients who have failed topical decolonization or who have documented colonization at multiple body sites.

Why MRSA Keeps Coming Back

One of the most frustrating aspects of MRSA nasal colonization is its tendency to recur. A community study found that about 44% of people who initially presented with MRSA skin infections had recurrent colonization after being cleared, with a median time to recolonization of about 53 days.26PubMed Central. Risk factors for recurrent colonization with methicillin-resistant Staphylococcus aureus in community-dwelling adults and children In a hospital study tracking re-admitted patients, about 59% of those who tested MRSA-positive on their first admission remained positive on every subsequent admission. The persistence depended heavily on which body sites were colonized: MRSA limited to wounds had a half-life of around 117 days, but colonization involving the nose alongside other sites persisted with a half-life of about 801 days.27PubMed Central. Long-term persistence of MRSA in re-admitted patients

Several forces drive this persistence. The nose is an ecological niche that MRSA is well-adapted to inhabit. Household surfaces, shared personal items, and even pets can serve as reservoirs that re-seed the nose after decolonization. Dogs and cats can carry MRSA strains that match the clones circulating in humans in the same area.28PubMed Central. Pet animals as reservoirs for spreading methicillin-resistant Staphylococcus aureus to human health Household environments more broadly may act as reservoirs for recolonization, potentially explaining why clearing the bacteria from a person’s body does not always stick.29The Lancet Infectious Diseases. Household transmission of Staphylococcus aureus and other staphylococci

The Role of the Nasal Microbiome

Emerging research suggests that the mix of other bacteria already living in your nose influences whether MRSA can establish itself there. In laboratory experiments using nasal microbiome samples from human donors, certain bacterial communities completely blocked MRSA growth. The samples that inhibited MRSA to undetectable levels were all dominated by members of the Enterobacteriaceae family at the experiment’s endpoint, even when those bacteria were not dominant in the original sample.30bioRxiv. Individual bacterial taxa drive colonisation resistance to methicillin-resistant Staphylococcus aureus in human nasal microbiome samples Separately, nasal Corynebacterium species appear to compete with staph for iron by hijacking iron-carrying molecules that staph produces for its own use.31The ISME Journal. Nasal commensals reduce Staphylococcus aureus proliferation by restricting siderophore availability

This line of research is still early-stage, but it raises an appealing possibility: instead of wiping out nasal bacteria with antibiotics and antiseptics (which may inadvertently remove the very organisms that keep MRSA in check), future approaches might promote or transplant protective bacterial communities. That concept is years away from clinical use, but it reframes nasal decolonization as an ecological problem rather than a purely antimicrobial one.

The Psychological Side of a Positive MRSA Swab

Getting told you’re a MRSA carrier can be unexpectedly distressing. In hospitals, it often means being placed in a private room, seeing staff enter in gowns and gloves, and having visitors follow extra precautions. A study of MRSA carriers in a hospital setting found that 56% reported stigma, with 14% experiencing what the researchers classified as clear stigma. About a third of carriers reported poor mental health, and stigma and mental health scores moved in opposite directions: more stigma, worse mental well-being.32Journal of Hospital Infection. Signs of stigma and poor mental health among carriers of MRSA

The isolation precautions are evidence-based for reducing transmission, but they can also leave patients feeling labeled or dirty. Hospital staff, family members, and patients themselves sometimes conflate colonization with active, contagious disease. If you or a family member tests positive, it helps to understand the distinction laid out earlier: carrying MRSA in your nose is common, it does not mean you are sick, and it does not make you a danger to healthy people in everyday social settings. Contact precautions in hospitals exist because hospitals are full of vulnerable patients with wounds, catheters, and weakened immune systems.

Screening Practices in Neonatal Units

MRSA screening takes on extra weight in neonatal intensive care units, where patients are small, immunologically immature, and frequently connected to invasive devices. A national survey of infection-prevention practitioners found that the vast majority of neonatal units (86%) screened patients for MRSA colonization, but there was substantial variation in how many body sites were swabbed, whether screening happened at admission, whether isolation precautions started before results came back, and whether decolonization therapy was used.33PubMed Central. Identification and eradication of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: results of a national survey Hospitals generally have well-established MRSA control programs for adult ICUs, but applying the same evidence to tiny patients introduces complications around drug dosing, skin sensitivity to antiseptics, and the practical challenges of isolating fragile neonates from their parents. Standardized evidence-based protocols for neonatal MRSA screening and decolonization remain a work in progress.

Hospital-Wide Screening Strategies

Hospitals face a trade-off between the breadth of their screening programs and the resources they consume. A modeling study compared several approaches and found that screening every patient on admission and weekly thereafter until discharge achieved the largest overall reduction in MRSA infections (about 77% over nine years) but required screening roughly 208 patients per day and prevented only one infection for every 9,700 screens. Focusing screening on ICU admissions alone cut the screening workload by 95% while still achieving a 66% hospital-wide reduction in MRSA infections and preventing one infection for every 103 screens.34Journal of Hospital Infection. Targeted versus universal screening and decolonization to reduce healthcare-associated meticillin-resistant Staphylococcus aureus infection The efficiency gap between those two policies is enormous, and most hospitals have landed on ICU-focused or risk-based screening as the pragmatic middle ground. Hospital staff, including healthcare workers who carry MRSA in their own noses, can also serve as a transmission bridge between patients.35PubMed Central. Molecular epidemiology of clinical and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the hospital settings of north India Periodic screening of healthcare workers during outbreaks is sometimes used to find and break those chains of transmission.